Factbox: New U.S. stock listings fail to impress in turbulent 2022

HilleVax

06/05/2022 17:36

May 6 (Reuters) - Eye care company Bausch + Lomb's decision
to price its initial public offering below range dashed the
hopes of a revival in the market for news issues as inflation
and geopolitical uncertainties play spoilsport.
    The few companies that have managed to list their shares on
Wall Street recently have seen lukewarm reception.
    Here is a list of stock performances of the biggest IPOs in
2022:
        
  U.S. listings    Month of    Capital        Stock
     in 2022       listing      raised     performance
                                           since debut
 TPG Inc  TPG.O    January      $1 bln       -21.2%
   Excelerate       April      $442 mln       -7.2%
   Energy Inc                             
      EE.N                                
      Credo        January     $200 mln       -9.8%
   Technology                             
  Group Holding                           
  Ltd  CRDO.O                             
  HilleVax Inc      April      $230 mln      -13.2%
     HLVX.O                               
  CinCor Pharma    January     $194 mln      +18.7%
  Inc  CINC.O                             
     Amylyx        January     $190 mln       -56%
 Pharmaceuticals                          
  Inc  AMLX.O                             
 Source: Refinitiv

 (Reporting by Niket Nishant in Bengaluru; Editing by Anil
D'Silva)
 ((Niket.Nishant@thomsonreuters.com;))